Minted: - / 5000

4972 Cerlapirdine
16697263b05f37b3aaa01d9c051a69b3278514a8218f3008bcfd9656ffd5148b

Properties

Background

Orange
Bottle

Light green
Cap

Light blue
Syringe

Gray
Bubbles
No
Drops
Yes
Label
Leaf

Chemistry

Formula
C22H23N3O3S
Carbon
22
Polarity
Neutral

Cerlapirdine (USAN; SAM-531, WAY-262,531, PF-05212365) is a drug which was under development by Wyeth/Pfizer for the treatment of cognitive disorders associated with Alzheimer's disease and schizophrenia. In a phase II clinical trial it demonstrated a trend toward efficacy along with a good side effect profile and no incidence of serious adverse events, but no further development has occurred since 2011.

From Wikipedia, the free encyclopedia. License: CC BY-SA.